Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Medline Inc. is a holding company and its only material assets are its equity interests held directly or indirectly through wholly owned subsidiaries in Medline Holdings, and it is accordingly dependent upon distributions from Medline Holdings to pay taxes, make payments under the tax receivable agreement, and pay any dividends. Medline Inc. is a holding company with no material assets other than its ownership of Common Units held directly or indirectly through wholly owned subsidiaries.
In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR
Business segments
Q2 2026 · $7.40BThe company’s own SEC segment disclosure.
- Acute Care$5.41B73%
- Non Acute Care$1.75B24%
- Laboratory And Diagnostics$248.0M3%
Medline Inc. (MDLN) reported revenue of $7.68B in Q2 2026 (quarter ended June 27, 2026), up 16% from the same quarter a year earlier. That came with a gross margin of 29% and net income of $139M (1.8% of revenue). For the full year FY2025, revenue was $28.4B (+11% year on year) and net income $1.16B. Its largest product in 2026-Q2 was Acute Care at $5.41B, 73% of the disclosed total, just ahead of Non Acute Care at 24%.
Raw charts
6 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
The closest names by size in the same industry